Crypto Med Innovation today announced that is it teaming up with an Indian Bio-Tech company to research and develop anti-viral flu remedies.
Online PR News – 15-June-2020 – Gangnam-gu/SEOUL – The flu market is the third-largest of its kind in the world and this new partnership is set to expand Crypto Med Innovation’s global portfolio and assets.
Crypto Med Innovation’s Chief Artificial Intelligence Officer, Mr. Bradley Hamilton PhD commented on the Indian partnership saying “The Coronavirus has caused hell throughout the world, and is only now being contained. While there is no cure yet, we are trying and testing different methods to see what fights it. Our focus is on nasal sprays and oral throat sprays and lozenges which we hope will become available to more than 60 million Indians by the start of next year.”
“It will be foolish not to look into expanding into new markets. Here at Crypto Med Innovation, we are consistently working on the continuous development of our platforms, particularly the growth of our products pipeline. Clinical phases for trials for acute treatment for viral pneumonia is in preparation stages,2 added Bradley Hamilton, Chief Artificial Intelligence Officer of Crypto Med Innovation.
About Us - Crypto Med Innovation
Based in South Korea’s capital city of Seoul, our mission here at Crypto Med Innovation is to transform the medical research field while providing personal health solutions through artificial intelligence and comprehensive data analysis. We aim to enable you to take control of your life by understanding your health, delivering vital information to allow healthcare professionals to deliver better-targeted care and treatment.
We at Crypto Med Innovation believe that information technology and artificial intelligence are the future and will propel humankind to new heights through better understanding. We aim to put your medical information in your hands and those who can provide effective healthcare solutions.